Suomi - suomi - Fimea (Suomen lääkevirasto)

lundbeck pharmaceuticals ireland limited - dactinomycinum - injektio/infuusiokuiva-aine, liuosta varten - 0.5 mg - daktinomysiini

Euroopan unioni - suomi - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Euroopan unioni - suomi - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamiinihappo, sitagliptiinifosfaattimonohydraattia - diabetes mellitus, tyyppi 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - steglujan on tarkoitettu aikuisille 18-vuotiaat ja vanhemmat, joilla on tyypin 2 diabetes lisänä ruokavalio ja liikunta parantaa glukoositasapainoa:kun metformiinin ja/tai sulfonyyliurean kanssa (su) ja yksi monocomponents ja steglujan eivät tarjoa riittävää glukoositasapainoa. potilaille, joita jo hoidettiin yhdistelmä ertugliflozin ja sitagliptiini erillisinä tabletteina.

Euroopan unioni - suomi - EMA (European Medicines Agency)

virbac s.a. - rekombinantti omena-interferoni kissan alkuperää - immunostimulantit, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. fiv: llä infektoiduilla kissoilla kuolleisuus oli alhainen (5%), eikä hoito vaikuttanut siihen.

Suomi - suomi - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - triglyserida mediocatenalia,soiae oleum raffinatum,argininum,kalii acetas,prolinum,histapyrrodini hydrochloridum,calcii chloridum dihydricum,natrii chloridum,natrii dihydrogenophosphas dihydricus,tryptophanum,zinci acetas dihydricus,valinum,acidum aminoaceticum,methioninum,lysini hydrochloridum,phenylalaninum,serinum,acidum asparticum,glucosum monohydricum,isoleucinum,leucinum,natrii hydroxidum,acidum glutamicum,magnesii acetas tetrahydricum,omega-3 acidorum triglycerida,natrii acetas trihydricus,threoninum - infuusioneste, emulsio - yhdistelmävalmisteet

Suomi - suomi - Fimea (Suomen lääkevirasto)

b. braun melsungen ag - serinum,natrii chloridum,tryptophanum,phenylalaninum,histapyrrodini hydrochloridum,acidum aminoaceticum,magnesii acetas tetrahydricum,calcii chloridum dihydricum,zinci acetas dihydricus,lysini hydrochloridum,soiae oleum raffinatum,threoninum,alaninum,omega-3 acidorum triglycerida,argininum,isoleucinum,kalii acetas,acidum glutamicum,valinum,natrii dihydrogenophosphas dihydricus,leucinum,prolinum,glucosum monohydricum,triglyserida mediocatenalia,natrii acetas trihydricus,natrii hydroxidum - infuusioneste, emulsio - yhdistelmävalmisteet